Africa & Middle East Social Commerce Market Intelligence Report 2024: Rising Usage of Social Media Platforms will Drive the Trend of Social Buying
DUBLIN, Feb. 16, 2024 /PRNewswire/ — The “Africa & Middle East Social Commerce Market Intelligence and Future Growth Dynamics Databook – 50+ KPIs on Social Commerce Trends by End-Use Sectors, Operational KPIs, Retail Product Dynamics, and Consumer Demographics – Q1 2024
ROSEN, THE FIRST FILING FIRM, Encourages Cummins Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – CMI
NEW YORK, Feb. 16, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cummins Inc. (NYSE: CMI) between April 30, 2019 and December 21, 2023, both dates inclusive (the “Class Period”), of the important March 15, 2024
ROSEN, A LEADING NATIONAL FIRM, Encourages BioVie Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BIVI
NEW YORK, Feb. 16, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioVie Inc. (NASDAQ: BIVI) between August 5, 2021 and November 29, 2023, both dates inclusive (the “Class Period”), of the important March 19, 2024 l
Hilary Swank and HealthyBaby Partner to Revolutionize Babycare for Today’s Parents
Swank Joins Disruptive Baby Brand as Chief Innovation Officer NEW YORK, Feb. 16, 2024 /PRNewswire/ — HealthyBaby, the challenger maternal health and babycare platform, is thrilled to announce Academy Award-Winning actor, entrepreneur and new mom, Hilary Swank, as the brand’s Partner and
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
NEW YORK, Feb. 16, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Renovaro Biosciences Inc. (NASDAQ: RENB) resulting from allegations that Renovaro may have issued materially m
YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting
GAITHERSBURG, Md., Feb. 16, 2024 /PRNewswire/ — YS Biopharma Co., Ltd. (Nasdaq: YS) (“YS Biopharma” or the “Company”), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biol
Medicom Recognized as One of the Most Promising Health IT Imaging Vendors of 2024 by KLAS Research
RALEIGH, N.C., Feb. 16, 2024 /PRNewswire/ — Medicom Technologies, Inc. (Medicom) proudly announces its recognition as one of the most promising IT vendors in Imaging in the Emerging HCIT Companies 2024 KLAS Research report. In a recent report released on January 16th, 2024, KLAS Research showc
Media Advisory – Prime Minister’s itinerary for Saturday, February 17, 2024
OTTAWA, ON, Feb. 16, 2024 /CNW/ – Note: All times local National Capital Region, Canada No public events scheduled This document is also available at https://pm.gc.ca SOURCE Prime Minister’s Office
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages GrafTech International Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EAF
NEW YORK, Feb. 16, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GrafTech International Ltd. (NYSE: EAF) between February 8, 2019 and August 3, 2023, both dates inclusive (the “Class Period”), of the important Ma
